Immunohistochemical Scores for Programmed Death Ligand-1 (PD-L1) Expression and Prognostic in Patients with Gastric Cancer

被引：0
|
作者：
Pereira, Marina A. [1 ]
Ramos, Marcus Fernando Kodama P. [1 ]
Ribeiro e Ribeiro, Renan [1 ]
Dias, Andre R. [1 ]
Ribeiro, Ulysses, Jr. [1 ]
Zilberstein, Bruno [1 ]
Cecconello, Ivan [1 ]
Mello, Evandro Sobroza [1 ]
Castria, Tiago B. [1 ]
机构：
[1] Univ Sao Paulo, Fac Med, Hosp Clin, Inst Canc, Sao Paulo, Brazil
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2020年 / 231卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：E208 / E208
页数：1
相关论文
共 50 条
  • [21] PROGRAMMED DEATH RECEPTOR LIGAND-1 (PD-L1) EXPRESSION IN A THYMOMA TISSUE MICROARRAY (TMA)
    Padda, Sukhmani Kaur
    Riess, Jonathan W.
    Schwartz, Erich Jurgen
    Tian, Lu
    Kohrt, Holbrook Edwin
    Neal, Joel W.
    West, Robert
    Wakelee, Heather A.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (10) : S212 - S212
  • [22] Programmed cell death ligand-1 (PD-L1) expression in desmoid tumors: a retrospective study
    Yildirim, A. N. Toksoz
    Akyurek, M.
    Okay, E.
    Zenginkinet, T.
    Iyetin, Y.
    Ozkan, K.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (11) : 5223 - 5229
  • [23] Different expression of programmed death 1 (PD1) and its ligand (PD-L1) in esophageal and gastric cancer
    Daster, Silvio
    Eppenberger-Castori, Serenella
    Droeser, Raoul A.
    Schaefer, Hannah M.
    Spagnoli, Giulio C.
    Terracciano, Luigi
    Tornillo, Luigi
    von Holzen, Urs
    CANCER RESEARCH, 2016, 76
  • [24] Mismatch Repair Deficiency (MMR-D) and Programmed Death Ligand-1 (PD-L1) Expression in Gastric Adenocarcinomas
    Jenkins, Taylor M.
    Tondon, Rashmi
    Wang, Li-Ping
    Ziober, Amy
    Lal, Priti
    Shroff, Stuti G.
    Furth, Emma E.
    Stashek, Kristen M.
    LABORATORY INVESTIGATION, 2017, 97 : 178A - 178A
  • [25] Mismatch Repair Deficiency (MMR-D) and Programmed Death Ligand-1 (PD-L1) Expression in Gastric Adenocarcinomas
    Jenkins, Taylor M.
    Tondon, Rashmi
    Wang, Li-Ping
    Ziober, Amy
    Lal, Priti
    Shroff, Stuti G.
    Furth, Emma E.
    Stashek, Kristen M.
    MODERN PATHOLOGY, 2017, 30 : 178A - 178A
  • [26] Prevalence of programmed death-1 ligand-1 (PD-L1) and infiltrating lymphocytes in human gastric carcinogenesis
    Liu, Zhonghua
    Wang, Yufang
    Luo, Xiaolei
    Wang, Yanyun
    Zhang, Lin
    Wang, Tao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (12): : 11754 - 11759
  • [27] Programmed death ligand-1 (PD-L1) expression in meningioma; prognostic significance and its association with hypoxia and NFKB2 expression
    Karimi, Shirin
    Mansouri, Sheila
    Mamatjan, Yasin
    Liu, Jeff
    Nassiri, Farshad
    Suppiah, Suganth
    Singh, Olivia
    Aldape, Kenneth
    Zadeh, Gelareh
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [28] Programmed death ligand-1 (PD-L1) expression in meningioma; prognostic significance and its association with hypoxia and NFKB2 expression
    Shirin Karimi
    Sheila Mansouri
    Yasin Mamatjan
    Jeff Liu
    Farshad Nassiri
    Suganth Suppiah
    Olivia Singh
    Kenneth Aldape
    Gelareh Zadeh
    Scientific Reports, 10
  • [29] Programmed cell death ligand-1 (PD-L1) expression by immunohistochemistry: could it be predictive and/or prognostic in non-small cell lung cancer?
    Mino-Kenudson, Mari
    CANCER BIOLOGY & MEDICINE, 2016, 13 (02) : 157 - 170
  • [30] Programmed cell death ligand-1(PD-L1) expression by immunohistochemistry: could it be predictive and/or prognostic in non-small cell lung cancer?
    Mari Mino-Kenudson
    Cancer Biology & Medicine, 2016, 13 (02) : 157 - 170
12345